Online inquiry

IVTScrip™ mRNA-Human ACYP2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK12483MR)

This product GTTS-WK12483MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ACYP2 protein. This product can be used in Oogenesis phase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001320586.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 98
UniProt ID P14621
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ACYP2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK12483MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK17493MR IVTScrip™ mRNA-Human ALDH16A1, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ALDH16A1
GTTS-WK14251MR IVTScrip™ mRNA-Human ACSM2A, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ACSM2A
GTTS-WK3245MR IVTScrip™ mRNA-Human CD10, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA CD10
GTTS-WK27552MR IVTScrip™ mRNA-Human ATG101, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ATG101
GTTS-WK28756MR IVTScrip™ mRNA-Human ATG16L2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ATG16L2
GTTS-WK20353MR IVTScrip™ mRNA-Human ANPEP, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ANPEP
GTTS-WK14170MR IVTScrip™ mRNA-Human ABHD5, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ABHD5
GTTS-WK21922MR IVTScrip™ mRNA-Human APOBEC3F, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA APOBEC3F
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW